Optiver Holding’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.3M Buy
874,000
+419,100
+92% +$18.7M 0.01% 256
2026
Q1
$21.9M Sell
454,900
-11,400
-2% -$532K 0.01% 268
2025
Q4
$22.6M Sell
466,300
-70,200
-13% -$3.48M 0.01% 239
2025
Q3
$25.3M Buy
536,500
+197,600
+58% +$9.54M 0.01% 206
2025
Q2
$16.4M Buy
338,900
+124,900
+58% +$6.38M 0.01% 159
2025
Q1
$11.9M Buy
214,000
+51,600
+32% +$2.79M 0.01% 166
2024
Q4
$7.83M Buy
+162,400
New +$8.26M ﹤0.01% 215

Other funds holding SNY

Optiver Holding's SNY Position: Q2 2026 in Review

Optiver Holding reduced its Sanofi (SNY) stake by 77% in Q2 2026, selling an estimated $16.9M and leaving 115,761 shares worth $4.94M. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Optiver Holding first reported a position in SNY in Q4 2021 and has held it in 15 quarters since. The position peaked at $38.6M in Q2 2023. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Optiver Holding held 115,761 shares of Sanofi worth $4.94M as of Q2 2026.
  • Optiver Holding sold 378,068 Sanofi shares in Q2 2026, an estimated $16.9M.
  • Sanofi made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #463 holding.
  • Optiver Holding first reported a position in Sanofi in Q4 2021 and has held it in 15 quarters since.
  • Optiver Holding's Sanofi position peaked at $38.6M in Q2 2023.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.